Publications by Professor Hermann Josef Vormoor - ePrints

Browsing publications by Professor Hermann Josef Vormoor.

Newcastle Authors	Title	Year
Liz Matheson Huw Thomas Marian Case Dr Helen Blair Rosanna Jackson et al.	Glucocorticoids and selumetinib are highly synergistic in RAS pathway mutated childhood acute lymphoblastic leukemia through upregulation of BIM	2019
Professor Olaf Heidenreich Professor Hermann Josef Vormoor	Epidemiology and biology of relapse after stem cell transplantation	2018
Professor Olaf Heidenreich Professor Hermann Josef Vormoor	The MLL recombinome of acute leukemias in 2017	2018
Dr Britta Vormoor Professor Gareth Veal Melanie Griffin Professor Julie Irving Lynne Minto et al.	A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia	2017
Dr Alex Elder Dr Simon Bomken Dr Ian Wilson Dr Helen Blair Dr Simon Cockell et al.	Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia	2017
Professor Andrew Pearson Dr Pamela Kearns Professor Hermann Josef Vormoor	Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective	2017
Professor Andrew Pearson Professor Hermann Josef Vormoor	From class waivers to precision medicine in paediatric oncology	2017
Professor Hermann Josef Vormoor Geoff Bell	"Including" Patients in the North. Development of an Early Phase Trials Network in the North of Britain	2016
Judith Weiland Dr Deepali Pal Marian Case Professor Julie Irving Dr Frida Ponthan et al.	BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance	2016
Dr Deepali Pal Professor Olaf Heidenreich Professor Hermann Josef Vormoor	Dormancy Stems the Tide of Chemotherapy	2016
Dr Lynsey McKenzie Dr Sirintra Nakjang Dr Helen Blair Professor Hermann Josef Vormoor Professor Olaf Heidenreich et al.	Identification of CCND2 As a RUNX1/ETO Target Required for Leukaemic Propagation	2016
Dr Deepali Pal Dr Helen Blair Dr Alex Elder Katie Dormon Dr Kate Rennie et al.	Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia	2016
Dr Alex Elder Dr Klaus Rehe Dr Simon Bomken Dr Paul Sinclair Katie Dormon et al.	The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.	2016
Katie Dormon Elda Latif Dr Matthew Bashton Dr Deepali Pal Dr Helen Blair et al.	A Whole Genome In Vivo Crispr Screen in Primary ALL Predicts Leukaemic Relapse	2015
Judith Weiland Dr Alex Elder Dr Victoria Forster Professor Olaf Heidenreich Professor Hermann Josef Vormoor et al.	CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia	2015
Dr Klaus Rehe Dr Simon Bomken Dr Paul Sinclair Dr Lisa Russell Professor Olaf Heidenreich et al.	Childhood pre-B acute lymphoblastic leukaemia cells capable of central nervous system engraftment are common, heterogeneous and transit the blood-cerebrospinal fluid barrier	2015
Dr Alex Elder Dr Helen Blair Katie Dormon Dr Simon Bomken Dr Simon Cockell et al.	High Abundance of Acute Lymphoblastic Leukaemia Founder Clones Does Not Translate to Functional Heterogeneity	2015
Dr Natalie Bell Dr Helen Blair Lisa Price Dr Katrina Wood Professor Hermann Josef Vormoor et al.	Patient-derived xenograft and in vivo bioluminescent modelling of B-cell NHL	2015
Professor Julie Irving Elizabeth Matheson Helen Blair Marian Case Isabella Swidenbank et al.	Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430	2015
Dr Frida Ponthan Dr Simon Bomken Dr Deepali Pal Dr Alex Elder Hesta McNeill et al.	A Genome-Wide RNAi Screen to Identify Novel Genes Involved in Clonal Maintenance of ALL	2014
Dr Britta Vormoor Henrike Knizia Michael Batey Dr Ian Wilson Dr Petra Dildey et al.	Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging	2014
Dr Natalie Bell Dr Helen Blair Professor Hermann Josef Vormoor Dr Christopher Bacon Dr Vikki Rand et al.	Development of in Vivo Models of Paediatric Burkitt Lymphoma Allowing Therapeutic Target Analysis and Drug Testing	2014
Dr Alex Elder Dr Simon Bomken Dr Helen Blair Professor Hermann Josef Vormoor Professor Olaf Heidenreich et al.	Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia	2014
Dr Simon Bomken Dr Helen Blair Professor Hermann Josef Vormoor Professor Olaf Heidenreich	Preclinical modelling of childhood acute lymphoblastic leukaemia	2014
Professor Julie Irving Elizabeth Matheson Dr Helen Blair Marian Case Isabella Swidenbank et al.	Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition	2014
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Dr Daniel Williamson Professor Julie Irving et al.	Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations	2013
Dr Simon Bomken Dr Lars Buechler Dr Klaus Rehe Dr Frida Ponthan Dr Alex Elder et al.	Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression	2013
Professor Olaf Heidenreich Professor Hermann Josef Vormoor	The MLL recombinome of acute leukemias in 2013	2013
Dr Lindsay Nicholson Elizabeth Matheson Lynne Minto Marian Case Maryna Sanichar et al.	Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia	2012
Professor Hermann Josef Vormoor	Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report	2012
Dr Alex Elder Professor Olaf Heidenreich Professor Hermann Josef Vormoor	Lentiviralmarking as a tool to investigate the clonal complexity and evolution of ALL	2012
Professor Hermann Josef Vormoor	Leukaemia & cancer in neonates	2012
Professor Hermann Josef Vormoor	The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study	2012
Dr Klaus Rehe Professor Olaf Heidenreich Professor Hermann Josef Vormoor Beth Gibson	Central Nervous System Involvement in a Xenograft Model of Pre-B Acute Lymphoblastic Leukaemia Is Associated with Dysfunctional CXCR4 Expression and Upregulation of the Neurotropic Chemokine Receptors CCR6 and CX3CR1	2011
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Professor Olaf Heidenreich Professor Hermann Josef Vormoor et al.	In acute lymphoblastic leukaemia stemness is frequent and ubiquitous	2011
Dr Simon Bomken Dr Lars Buechler Dr Klaus Rehe Dr Frida Ponthan Dr Helen Blair et al.	Lentiviral Transduction of Patient Derived Leukaemic Blasts Allowing In Vivo Bioluminescent Monitoring in An NSG Model of Leukaemia Stem Cell Maintenance	2011
Dr Frida Ponthan Hesta McNeill Dr Lars Buechler Professor Hermann Josef Vormoor Professor Olaf Heidenreich et al.	Significance of Fusion Genes for Maintenance of Leukaemia	2011
Patricia Garrido Castro Dr Simon Bomken Elda Latif Michael Batey Hesta McNeill et al.	ANGIOPOIETIN1 a Novel Factor Implicated In MLL Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene Dependent Manner	2010
Patricia Garrido Castro Dr Simon Bomken Professor Hermann Josef Vormoor Professor Olaf Heidenreich	ANGIOPOIETIN-1 expression is modulated by leukaemic fusion genes	2010
Elda Latif Michael Batey Hesta McNeill Professor Hermann Josef Vormoor Professor Olaf Heidenreich et al.	ANGIOPOIETIN1-a Novel Factor Implicated In MLL-Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene-Dependent Manner	2010
Professor Hermann Josef Vormoor	Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo	2010
Henrike Knizia Michael Batey Gilberto de Almeida Dr Ross Maxwell Dr Petra Dildey et al.	Development of an orthotopic model for human malignant bone diseases in immunocompromised NOD.Cg-Prkdc^scidIl2rg^tmlwjl/szj (NSG) mice	2010
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Hesta McNeill Professor Julie Irving et al.	In Acute Lymphoblastic Leukaemia, Stemness Is Frequent and Ubiquitous	2010
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Hesta McNeill Professor Julie Irving et al.	In Acute Lymphoblastic Leukaemia, Sternness Is Frequent and Ubiquitous	2010
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Hesta McNeill Professor Julie Irving et al.	In acute lymphoblastic leukemia, stemness is frequent and ubiquitous	2010
Dr Klaus Rehe Kerrie Wilson Hesta McNeill Professor Julie Irving Professor Hermann Josef Vormoor et al.	In standard and high risk acute lymphoblastic leukemias disease propagating cells are abundant and not confined to certain immunophenotypic fractions	2010
Dr Andreas Gessner Patricia Garrido Castro Dr Anja Scholz Professor Hermann Josef Vormoor Professor Olaf Heidenreich et al.	Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT	2010
Dr Simon Bomken Dr Svetlana Mysina Professor Olaf Heidenreich Professor Hermann Josef Vormoor	The Germline Stem Cell Self-Renewal Gene PIWIL2 is Expressed in Both Malignant and Non-Malignant Lymphoid Cells	2010
Dr Simon Bomken Professor Hermann Josef Vormoor Professor Olaf Heidenreich	The Prosurvival Cytokine Angiopoietin-1 is Overexpressed in T(4;11)-Positive ALL and Regulated in a MLL/AF4 Dependent Manner	2010
Dr Simon Bomken Dr Karel Fiser Professor Olaf Heidenreich Professor Hermann Josef Vormoor	Understanding the cancer stem cell	2010
Professor Hermann Josef Vormoor	A new subgroup of high-risk acute lymphoblastic leukaemia	2009
Patricia Garrido Castro Dr Andreas Gessner Joachim Greiling Professor Hermann Josef Vormoor Professor Olaf Heidenreich et al.	Caspase inhibition blocks apoptosis caused by MLL-AF4 depletion in t(4;11) positive ALL cell lines, but cannot abrogate subsequent necroptosis-like cell death	2009
Dr Andreas Gessner Professor Olaf Heidenreich Professor Hermann Josef Vormoor	Caspase inhibition blocks apoptosis caused by MLL-AF4 depletion in t(4;11)-positive ALL cell lines, but cannot abrogate subsequent necroptosis-like cell death	2009
Professor Hermann Josef Vormoor	CD19-Redirected Cytotoxic T Cells Prevent Engraftment of Primary Human Leukemia Cells In Vivo	2009
Dr Simon Bomken Professor Hermann Josef Vormoor	Childhood leukaemia	2009
Dr Klaus Rehe Kerrie Wilson Hesta McNeill Professor Hermann Josef Vormoor	Disease Propagating Blasts in Standard and High Risk Acute Lymphoblastic Leukemia Are Frequent and of Diverse Immunophenotype	2009
Kate Wilson Marian Case Lynne Minto Professor Simon Bailey Dr Nicholas Bown et al.	Flow minimal residue disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34⁺CD38^lowCD19⁺ in B-lineage childhoood acute lymphoblastic leukemia	2009
Professor Hermann Josef Vormoor	Malignant stem cells in childhood acute lymphoblastic leukemia: The stem cell concept revisited	2009
Professor Olaf Heidenreich Professor Hermann Josef Vormoor	Malignant stem cells in childhood ALL: the debate continues!	2009
Richard Feltbower Dr Richard McNally Professor Stephen Proctor Professor Roderick Skinner Professor Hermann Josef Vormoor et al.	The epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-2002	2009
Professor Hermann Josef Vormoor	Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice	2008
Dr Simon Bomken Kerrie Wilson Professor Julie Irving Professor Hermann Josef Vormoor	In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties	2008
Kerrie Wilson Dr Klaus Rehe Dr Simon Bomken Marian Case Professor Julie Irving et al.	In Childhood ALL, Both Blasts with a CD20(-/Low) and a CD20(High) Immunophenotype, Have the Ability to Transfer the Leukemia Onto Immune-Deficient NOD/Scid Y-/- Mice	2008
Professor Hermann Josef Vormoor	Long term follow-up in three pediatric patients with Farber Disease, Type 2/3, following allogeneic hematopoietic stem cell transplantation from related and unrelated donors	2008
Dr Karel Fiser Professor Julie Irving Professor Hermann Josef Vormoor	MRD Monitoring of Childhood ALL Using Hierarchical Clustering and Support Vector Machine Learning of Complex Multi-Parameter Flow Cytometry Data	2008
Marian Case Elizabeth Matheson Lynne Minto Dr Nicholas Bown Professor Simon Bailey et al.	Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia	2008
Professor Hermann Josef Vormoor	Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients	2008
Marian Case Elizabeth Matheson Lynne Minto Professor Christine Harrison FRCPath FMedSci Dr Nicholas Bown et al.	Somatic mutation of genes impacting on the RAS-RAF-MEK-ERK pathway is the most common genetic abnormality in childhood acute lymphoblastic leukaemia, is implicated in disease progression and provides a rationale for therapeutic targeting	2008
Kerrie Wilson Marian Case Lynne Minto Professor Simon Bailey Professor Hermann Josef Vormoor et al.	The CD34⁺ CD38^Low CD19⁺ Candidate Leukemic Stem Cell Phenotype Revisited: Useful for Flow MRD Monitoring?	2008
Professor Hermann Josef Vormoor	Characterisation of candidate malignant stem cell populations in childhood B-cell precusor acute lymphoblastic leukaemia	2007
Professor Hermann Josef Vormoor	Characterisation of the stem cell compartment in childhood ALL	2007
Professor Hermann Josef Vormoor	Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan	2007
Professor Hermann Josef Vormoor	Farber disease: Clinical presentation, pathogenesis and a new approach to treatment	2007
Dr Karel Fiser Professor Hermann Josef Vormoor	Identifying candidate normal and leukemic B cell progenitor populations with hierarchical clustering of 6-color flow cytometry data - A better view	2007
Henrike Knizia Professor Hermann Josef Vormoor	Identifying cellular mechanisms of organ-specific metastasis of Ewing tumours	2007
Professor Hermann Josef Vormoor	Identifying the acute lymphoblastic leukemia stem cell	2007
Professor Hermann Josef Vormoor	Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia	2007
Professor Hermann Josef Vormoor	Bordetella pertussis respiratory infection following hematopoietic stem cell transplantation: time for universal vaccination?	2006
Professor Hermann Josef Vormoor	CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells	2006
Professor Hermann Josef Vormoor	CD34+CD19-, CD34+CD19+ and CD34-CD19+ cells may all have leukemia-initiating potential in NOD/Scid mice	2006
Professor Hermann Josef Vormoor	Farber's disease without central nervous system involvement: Bone-marrow transplantation provides a promising new approach [1]	2006
Professor Hermann Josef Vormoor	Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system–negative stage III or IV lymphoblastic lymphoma	2006
Professor Hermann Josef Vormoor	Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11)	2006
Professor Hermann Josef Vormoor	No improvement of overall-survival in children with high-risk acute myeloid leukemia by stem cell transplantation in 1st complete remission	2006
Professor Hermann Josef Vormoor	Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome	2006
Professor Hermann Josef Vormoor	PET/CT with diagnostic CT in the evaluation of childhood sarcoma	2006
Professor Hermann Josef Vormoor	Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model	2006
Professor Hermann Josef Vormoor	Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors	2006
Professor Hermann Josef Vormoor	Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide	2006
Professor Hermann Josef Vormoor	Whole-Body PET/CT with ¹¹C-Meta-Hydroxyephedrine in tumors of the sympathetic nervous system: Feasibility study and comparison with ¹²³I-MIBG SPECT/CT	2006
Professor Hermann Josef Vormoor	Adoptive cellular immunotherapy with CD19-specific T cells	2005
Professor Hermann Josef Vormoor	Agressive fibromatosis involving the mandible: Case report and review of the literature	2005
Professor Hermann Josef Vormoor	Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy	2005
Professor Hermann Josef Vormoor	Duration of storage of autologous hematopoietic stem cell products for children and adolescents with malignant diseases	2005
Professor Hermann Josef Vormoor	Heterogeneity of radiation induced apoptosis in Ewing Tumor cell lines characterized on a single cell level	2005
Professor Hermann Josef Vormoor	Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning	2005
Professor Hermann Josef Vormoor	Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34⁺CD19^- cells	2005
Professor Hermann Josef Vormoor	Metastatic neuroblastoma demonstrated by whole-body PET-CT using 11C-HED	2005
Professor Hermann Josef Vormoor	PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death	2005
Professor Hermann Josef Vormoor	Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantation	2005
Professor Hermann Josef Vormoor	Changed adhesion molecule profile of Ewing tumor cell lines and xenografts under the influence of ionizing radiation	2004
Professor Hermann Josef Vormoor	Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukaphereses with standardized processing volumes	2004
Professor Hermann Josef Vormoor	Haematopoetic stem cell transplantation for refractory autoimmune cytopenia	2004
Professor Hermann Josef Vormoor	Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity	2004
Professor Hermann Josef Vormoor	Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective	2004
Professor Hermann Josef Vormoor	Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation	2004
Professor Hermann Josef Vormoor	Successful hematopoietic stem cell transplantation in Farber disease	2004
Professor Hermann Josef Vormoor	Unique SDF-1–induced activation of human precursor-BALL cells as a result of altered CXCR4 expression and signaling	2004
Professor Hermann Josef Vormoor	Durable clearance of hepatitis B virus after allogeneic blood stem cell transplantation by adoptive immunity transfer and antiviral chemotherapy	2003
Professor Hermann Josef Vormoor	Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level: intracellular cytokine, immunophenotypic, DNA and apoptotic profile	2003
Professor Hermann Josef Vormoor	Identification of two distinct subpopulations in a ganglioneuroblastoma: lack of co-localization of vasoactive intestinal polypeptide and calcitonin in ganglionic cells at the ultrastructural level	2003
Professor Hermann Josef Vormoor	Osteosarcoma after allogeneic bone marrow transplantation: A report of four cases from the Cooperative Osteosarcoma Study Group (COSS)	2003
Professor Hermann Josef Vormoor	Time- and dose-dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation	2003
Professor Hermann Josef Vormoor	Binding of two nuclear complexes to a novel regulatory element within the human S100A9 promoter drives the S100A9 gene expression	2002
Professor Hermann Josef Vormoor	c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571)	2002
Professor Hermann Josef Vormoor	Current state of cord blood transplantation in childhood	2002
Professor Hermann Josef Vormoor	Immature CD34⁺CD19^- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal	2002
Professor Hermann Josef Vormoor	Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study	2002
Professor Hermann Josef Vormoor	Targeting CD19 with genetically modified EBV-specific human T lymphocytes	2002
Professor Hermann Josef Vormoor	Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia	2001
Professor Hermann Josef Vormoor	Establishment of an in vivo model for pediatric Ewing tumors by transplantation into NOD/scid mice	2001
Professor Hermann Josef Vormoor	Cell heterogeneity and subpopulations in solid tumors characterized by simultaneous immunophenotyping and DNA content analysis	2000
Professor Hermann Josef Vormoor	Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia	1999
Professor Hermann Josef Vormoor	Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism	1999
Professor Hermann Josef Vormoor	Flow cytometric identification of candidate normal stem cell populations in CD45-negative B-cell precursor acute lymphoblastic leukaemia	1998
Professor Hermann Josef Vormoor	Good engraftment of B-cell precursor ALL in NOD-SCID mice	1997
Professor Hermann Josef Vormoor	Flow cytometric characterization of differentiation events and primitive stem cell populations in childhood B-cell precursor ALL	1996
Professor Hermann Josef Vormoor	Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice	1996
Professor Hermann Josef Vormoor	Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy	1996
Professor Hermann Josef Vormoor	Myelodysplasia and acute myelogenous leukemia in Down's syndrome: A report of 40 children of the AML-BFM Study Group	1996
Professor Hermann Josef Vormoor	Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis	1996
Professor Hermann Josef Vormoor	Therapy of childhood acute myelogenous leukemias	1996
Professor Hermann Josef Vormoor	Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols	1995
Professor Hermann Josef Vormoor	A cell initiating human acute myeloid leukaemia after transplantation into SCID mice	1994
Professor Hermann Josef Vormoor	Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice	1994
Dr Andrew Hall Professor Hermann Josef Vormoor	Increased DNA-repair capacity and the modulation of 2 proteins in and metallothionein overexpressing Chinese hamster cell line	1994
Professor Hermann Josef Vormoor	SCID mice as an in vivo model of human cord blood hematopoiesis	1994
Professor Hermann Josef Vormoor	High-level multilineage engraftment of human cord blood cells in SCID mice	1993
Professor Hermann Josef Vormoor	Acute myelogenous leukaemia in children under 2 years: Experiences of the West German AML studies BFM-78, -83 and -87	1992
Professor Hermann Josef Vormoor	Transient myeloproliferative disorders and acute myelogenous leukemia in infants with Down's syndrome	1990
Professor Hermann Josef Vormoor	Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83	1989
Professor Hermann Josef Vormoor	Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83	1989